The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors-Reference-Cited by-同舟云学术

The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors

Published:2016-09-28 Issue:10 Volume:10 Page:9243-9258
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Miao Lei¹,Newby Jay M.¹,Lin C. Michael¹,Zhang Lu¹,Xu Feifei¹,Kim William Y.¹,Forest M. Gregory¹,Lai Samuel K.¹,Milowsky Matthew I.¹,Wobker Sara E.¹,Huang Leaf¹

Affiliation:

1. Division of Molecular Pharmaceutics and Center of Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, ‡Lineberger Comprehensive Cancer Center, §Departments of Mathematics and Applied Physical Science, ∥Department of Medicine, ⊥Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.6b02776

Reference53 articles.

1. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities

2. The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles

3. Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer;ACS Applied Bio Materials;2024-08-28

2. Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy;Acta Pharmaceutica Sinica B;2024-08

3. Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review;Cancers;2024-07-27

4. Advances in 2,3-Dimethylmaleic Anhydride (DMMA)-Modified Nanocarriers in Drug Delivery Systems;Pharmaceutics;2024-06-14

5. Biomimetic “nano-spears” for CAFs-targeting: splintered three “shields” with enhanced cisplatin anti-TNBC efficiency;Journal of Controlled Release;2024-06